Therefore, similar to the better-characterized mitofusin-2, it is expected that PACS-2 acts as a tumor suppressor (Figures 1 and 2), whose absence would be indeed expected to lead to ER–mitochondria uncoupling, but this has not been determined at this point. Here, MFN2 is linked to neoplasm.